Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stereotaxis (STXS)
:STXS
Holding STXS?
Track your performance easily
STXS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.66 - $3.29
Previous CloseN/A
Volume282.58K
Average Volume (3M)381.99K
Market Cap
$177.93M
Enterprise Value$175.61M
Total Cash (Recent Filing)$8.50M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Mar 18, 2025EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding84,729,510
10 Day Avg. Volume408,458
30 Day Avg. Volume381,994
Standard Deviation0.18
R-Squared0.21
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.08
Price to Cash Flow (P/CF)-10.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue6.98
Enterprise Value/Gross Profit11.82
Enterprise Value/Ebitda-9.49
Forecast
1Y Price Target
$4.33Price Target Upside104.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Stereotaxis News
PremiumCompany Announcements
Stereotaxis Reports Strong Q3 Growth in Robotics
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSTXS delivered a strong 3Q performance and comfortably beat consensus expectations.
Product DevelopmentMAGiC approval in Europe is expected soon, with positive interactions in the U.S., potentially unlocking significant revenue opportunities.
Strategic GrowthStereotaxis is transforming its endovascular robotic offering with the addition of a new robot (GenesisX), new disposable (MAGiC), and platform optionality (new indications).
Bears Say
EarningsRevenue totaled $4.5M, down from $7.9M in the prior-year period and short of the Street's $5.6M consensus estimate.
Financial PerformanceGross margin for the quarter was 45% compared to 52% last year, indicating a decline in profitability.
ProfitabilitySystem gross margin stood at a low 16%, which could impact overall company profitability.
---
Ownership Overview
22.94% Insiders
6.55% Mutual Funds
0.57% Other Institutional Investors
63.99% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STXS FAQ
What was Stereotaxis’s price range in the past 12 months?
Stereotaxis lowest stock price was $1.66 and its highest was $3.29 in the past 12 months.
What is Stereotaxis’s market cap?
Stereotaxis’s market cap is $177.93M.
When is Stereotaxis’s upcoming earnings report date?
Stereotaxis’s upcoming earnings report date is Mar 18, 2025 which is in 59 days.
How were Stereotaxis’s earnings last quarter?
Stereotaxis released its earnings results on Nov 11, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.052 by -$0.028.
Is Stereotaxis overvalued?
According to Wall Street analysts Stereotaxis’s price is currently Undervalued.
Does Stereotaxis pay dividends?
Stereotaxis does not currently pay dividends.
What is Stereotaxis’s EPS estimate?
Stereotaxis’s EPS estimate is -0.07.
How many shares outstanding does Stereotaxis have?
Stereotaxis has 84,729,510 shares outstanding.
What happened to Stereotaxis’s price movement after its last earnings report?
Stereotaxis reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.052. Following the earnings report the stock price went up 22.162%.
Which hedge fund is a major shareholder of Stereotaxis?
Currently, no hedge funds are holding shares in STXS
---
Stereotaxis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.33 (104.25% Upside)
$4.33 (104.25% Upside)
Blogger Sentiment
Bullish
STXS Sentiment 70%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.2%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.04%
12-Months-Change
Fundamentals
Return on Equity
-106.46%
Trailing 12-Months
Asset Growth
14.39%
Trailing 12-Months
Company Description
Stereotaxis
Stereotaxis, Inc. engages in the design, manufacture, and market of robotic systems and instruments that electrophysiologists use for the treatment of abnormal heart rhythms known as cardiac arrhythmias. Its products include The Epoch Solution, Niobe Magnetic Navigation System, Vdrive Robotic Navigation System, and Odyssey Solution. The company was founded in June 1990 and is headquartered in St. Louis, MO.
---
STXS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and successful integration of APT, alongside promising developments in product innovation, particularly in the European market. However, challenges remain in the U.S. and China markets due to delayed regulatory approvals, and there were notable operating losses. The sentiment is balanced by strong progress and future potential, tempered by current financial and regional challenges.Read More>---
STXS Stock 12 Month Forecast
Average Price Target
$4.33
▲(104.25% Upside)
Technical Analysis
Best Analysts Covering STXS
1 Year
1 Year Success Rate
5/14 ratings generated profit
1 Year Average Return
+1.01%
reiterated a buy rating last month
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of +1.01% per trade.
---